Table 1.
Proposed category system | Type of syndrome | % of general population | % of those with thrombosis |
---|---|---|---|
1. Qualitative and quantitative defects of those factors inhibiting clotting | Antithrombin deficiency | 0.2 | 1-3 |
Protein C deficiency | 0.2-0.4 | 3-5 | |
Protein S deficiency | 0.03-0.1 | 1-5 | |
Heparin cofactor II deficiency | ~ 1 | ~ 1 | |
Tissue factor pathway inhibitor deficiency | a | a | |
Thrombomodulin deficiency | a | a | |
2. Qualitative and quantitative defects of those factors promoting clotting | Activated protein C resistance and factor V Leiden | 5 | 10-50 |
Prothrombin gene mutation | 2-5 | 6-18 | |
Dysfibrinogenemia and hyperfibrinogenemia | < 1 | < 1 | |
Elevated levels of clotting factors VIII | 11 | 25 | |
Elevated levels of clotting factors VII, IX, XI, and XII | a | a | |
3. Hyperhomocysteinemia | 5 | 10 | |
4. Defects of the fibrinolytic system | Plasminogen | a | a |
Tissue plasminogen activator | a | a | |
Thrombin-activatable fibrinolysis | a | a | |
Factor XIII | a | a | |
Lipoprotein (a) | a | a | |
5. Altered platelet function | Platelet glycoprotein GPIb-IX | a | a |
GPIa-IIa | a | a | |
GPIIb-IIIa | a | a |
Modified table republished with permission from Informa Healthcare, Copyright 2006. Franchini M, Veneri D, Salvagno GL, Manzato F, Lippi G. Inherited thrombophilia. Crit Rev Clin Lab Sci 2006;43:249-90.
Percentages unknown or not reported.